Live News EQUITY M impact Jun 23, 2026, 11:00 AM UTC

AMLX Presents ALS Trial Data

Amylyx Pharmaceuticals presents data from first-in-human, dose-ranging Phase 1 LUMINA trial of AMX0114 in ALS at ENCALS 2026

SQUAWKNEWS Updated Jun 23, 2026, 11:00 AM UTC

AMLX Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026